CliffBio
small molecule

DULERA

FORMOTEROL FUMARATE; MOMETASONE FUROATE

Loss of exclusivity—loss of exclusivity
CompanyOrganon →See this company's full patent-cliff portfolio

Drug detail

Brand nameDULERA
Active ingredientFORMOTEROL FUMARATE; MOMETASONE FUROATE
Strength0.005MG/INH;0.05MG/INH
Dosage formAEROSOL, METERED
RouteINHALATION
ModalitySmall molecule
FDA approvalAugust 2019
Marketing statusRX

More from Organon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

DULERA patent cliff — loss of exclusivity — | CliffBio